Epidemiología e historia natural de la hepatopatía grasa no alcohólica primaria

Moreno Sánchez, 1989, Esteatohepatitis no alcohólica, An Med Intern (Madrid), 6, 100 Moreno Sánchez, 1993, El hígado en la obesidad, Gastroenterol Hepatol, 16, 550 Caballería, 2003, Esteatohepatitis no alcohólica, Med Clin (Barc), 120, 670, 10.1016/S0025-7753(03)73803-2 Clemente Ricote, 2003, Estado actual de la esteatohepatitis no alcohólica, Med Clin (Barc), 121, 102, 10.1016/S0025-7753(03)73870-6 Moreno Sánchez, 2005, Patogenia de la hepatopatía grasa no alcohólica primaria, Med Clin (Barc), 124, 668, 10.1157/13074744 Harrison, 2003, Advances in the understanding and treatment of nonalcoholic fatty liver disease, Drugs, 63, 2379, 10.2165/00003495-200363220-00001 Reaven, 1999, Syndrome X: 10 years after, Drugs, 58, 19, 10.2165/00003495-199958001-00006 Castellano Tortajada, 1992, Esteatohepatitis no alcohólica, ¿una nueva entidad?, 1, 103 Moreno Sánchez, 1987, Esteatohepatitis no alcohólica. Estudio clinicoanalítico de 40 casos, Med Clin (Barc), 89, 188 Ludwig, 1980, Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hither to unnamed disease, Mayo Clin Proc, 55, 434 Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114 Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193 Zafrani, 2004, Non-alcoholic fatty liver disease: an emerging pathological spectrum, Virchows Arch, 444, 3, 10.1007/s00428-003-0943-7 Moreno Sánchez, 2005, Tratamiento médico de la hepatopatía grasa no alcohólica primaria, Med Clin (Barc), 125, 108, 10.1157/13076737 2000, Consenso SEEDO’2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica, Med Clin (Barc), 115, 587, 10.1016/S0025-7753(00)71632-0 Collantes, 2004, Nonalcoholic fatty liver disease and the epidemic of obesity, Cleve Clin J Med, 71, 657, 10.3949/ccjm.71.8.657 Roth, 2004, The obesity pandemic: where have we been and where are we going?, Obes Res, 12, 88, 10.1038/oby.2004.273 Lonardo, 1997, The bright liver syndrome: prevalence and determinants of a «bright» liver echo pattern, Ital J Gastroenterol Hepatol, 29, 351 Omagari, 2002, Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics, J Gastroenterol Hepatol, 17, 1098, 10.1046/j.1440-1746.2002.02846.x El-Hassan, 1992, Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management, Br J Radiol, 65, 774, 10.1259/0007-1285-65-777-774 Hultcrantz, 1986, Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases, Scand J Gastroenterol, 21, 109, 10.3109/00365528609034632 Propst, 1995, Prognosis in nonalcoholic steatohepatitis, Gastroenterology, 108, 1607, 10.1016/0016-5085(95)90724-6 Nonomura, 1992, Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis, Gastroenterol Jpn, 27, 521, 10.1007/BF02777789 Marceau, 1999, Liver pathology and the metabolic syndrome X in severe obesity, J Clin Endocrinol Metab, 84, 1513, 10.1210/jc.84.5.1513 Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 Del Gaudio, 2002, Liver damage in obese patients, Obes Surg, 12, 802, 10.1381/096089202320995592 Beymer, 2003, Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery, Arch Surg, 138, 1240, 10.1001/archsurg.138.11.1240 Shalhub, 2004, The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients, Obes Surg, 14, 54, 10.1381/096089204772787293 Wanless, 1990, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors, Hepatology, 12, 1106, 10.1002/hep.1840120505 Nomura, 1988, Prevalence of fatty liver in a general population of Okinawa, Japan, Jpn J Med, 27, 142, 10.2169/internalmedicine1962.27.142 Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004 Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, E462, 10.1152/ajpendo.00064.2004 Hilden, 1977, Liver histology in a «normal» population examinations of 503 consecutive fatal traffic casualties, Scand J Gastroenterol, 12, 593, 10.3109/00365527709181339 Ground, 1982, Liver pathology in aircrew, Aviat Space Environ Med, 53, 14 Daniel, 1999, Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients, Am J Gastroenterol, 94, 3010, 10.1111/j.1572-0241.1999.01451.x Clark, 2001, Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the U.S. population, Gastroenterology, 120, A65, 10.1016/S0016-5085(01)80321-8 Clark, 2002, Nonalcoholic fatty liver disease, Gastroenterology, 122, 1649, 10.1053/gast.2002.33573 Clark, 2003, Nonalcoholic fatty liver disease: an underrecognized cause of criptogenic cirrhosis, JAMA, 289, 3000, 10.1001/jama.289.22.3000 Clark, 2003, The prevalence and etiology of elevated aminotransferase levels in the United States, Am J Gastroenterol, 98, 960, 10.1111/j.1572-0241.2003.07486.x De Ledinghen, 2004, Should a liver biopsy be done in patients with subclinical chronically elevated transaminases?, Eur J Gastroenterol Hepatol, 16, 879, 10.1097/00042737-200409000-00011 Caldwell, 1999, Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease, Hepatology, 29, 664, 10.1002/hep.510290347 Poonawala, 2000, Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a casecontrol study, Hepatology, 32, 689, 10.1053/jhep.2000.17894 Browning, 2004, Ethnic differences in the prevalence of cryptogenic cirrhosis, Am J Gastroenterol, 99, 292, 10.1111/j.1572-0241.2004.04059.x Sutedja, 2004, Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy, Transplant Proc, 36, 2334, 10.1016/j.transproceed.2004.07.003 Ruhl, 2003, Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States, Gastroenterology, 124, 71, 10.1053/gast.2003.50004 Prati, 2002, Updated definitions of healthy ranges for serum alanine aminotransferase levels, Ann Intern Med, 137, 1, 10.7326/0003-4819-137-1-200207020-00006 Clark, 2003, Defining nonalcoholic fatty liver disease: implications for epidemiologic studies, Gastroenterology, 124, 248, 10.1053/gast.2003.50032 Viral hepatitis. Department of Health and Human Services, Center for Disease Control and Prevention National Center for Health Statistics [consultado 07/11/2002]. Disponible en: http://www.cdc.gov/nchs/data/nhanes/databriefs/viralhep.pdf Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775 Flegal, 1998, Overweight and obesity in the United States: prevalence and trends, 1960-1994, Int J Obes Relat Metab Disord, 22, 39, 10.1038/sj.ijo.0800541 Silverman, 1990, Liver pathology in morbidly obese patients with and without diabetes, Am J Gastroenterol, 84, 1349 Harris, 1998, Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey. 1988-1994, Diabetes Care, 21, 518, 10.2337/diacare.21.4.518 Creutzfeldt, 1970, Liver diseases and diabetes mellitus, Prog Liver Dis, 3, 371 Bellentani, 2004, The epidemiology of fatty liver, Eur J Gastroenterol Hepatol, 16, 1087, 10.1097/00042737-200411000-00002 Kopelman, 2000, Obesity as a medical problem, Nature, 404, 635, 10.1038/35007508 Boyle, 2001, Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US, Diabetes Care, 24, 1936, 10.2337/diacare.24.11.1936 Flegal, 1996, Trends in body weight and overweight in the U.S. population, Nutr Rev, 54, S97, 10.1111/j.1753-4887.1996.tb03903.x Flegal, 2002, Prevalence and trend in obesity among US adults, 1999-2000, JAMA, 288, 1723, 10.1001/jama.288.14.1723 Okosun, 2004, Abdominal adiposity in U.S. adults: prevalence and trends, 1960-2000, Prev Med, 39, 197, 10.1016/j.ypmed.2004.01.023 Mokdad, 2001, The continuing epidemic of obesity and diabetes in the United States, JAMA, 286, 1195, 10.1001/jama.286.10.1195 Sanyal, 2002, AGA technical review of nonalcoholic fatty liver disease, Gastroenterology, 123, 1705, 10.1053/gast.2002.36572 Weiss, 2004, Obesity and the metabolic syndrome in children and adolescents, N Engl J Med, 350, 2362, 10.1056/NEJMoa031049 Lavine, 2004, Nonalcoholic fatty liver disease in the pediatric population, Clin Liver Dis, 8, 549, 10.1016/j.cld.2004.04.010 Itoh, 1987, Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis, Am J Gastroenterol, 82, 650 Diehl, 1988, Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury, Gastroenterology, 95, 1056, 10.1016/0016-5085(88)90183-7 Lee, 1989, Nonalcoholic steatohepatitis: a study of 49 patients, Hum Pathol, 20, 594, 10.1016/0046-8177(89)90249-9 Pinto, 1996, Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients, Dig Dis Sci, 41, 172, 10.1007/BF02208601 Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 García-Monzón, 2000, Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity, J Hepatol, 33, 716, 10.1016/S0168-8278(00)80301-3 Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8 Shimada, 2002, Nonalcoholic steatohepatitis: risk factors for liver fibrosis, Hepatol Res, 24, 429, 10.1016/S1386-6346(02)00246-2 Bacon, 1994, Nonalcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6 Teli, 1995, The natural history of nonalcoholic fatty liver: a follow-up study, Hepatology, 22, 1714, 10.1002/hep.1840220616 Harrison, 2002, Clinical factors associated with fibrosis in 102 patients with non-alcoholic steatohepatitis, Hepatology, 36, 412A Chitturi, 2002, HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity, Hepatology, 36, 142, 10.1053/jhep.2002.33892 Sinha, 2002, Prevalence of impaired glucose tolerance among children and adolescents with marked obesity, N Engl J Med, 346, 1756, 10.1056/NEJMoa012578 Baldridge, 1995, Idiopathic steatohepatitis in childhood: a multicenter retrospective study, J Pediatr, 127, 700, 10.1016/S0022-3476(95)70156-7 Rashid, 2000, Nonalcoholic steatohepatitis in children, J Pediatr Gastroenterol Nutr, 30, 48, 10.1097/00005176-200001000-00017 Strauss, 2000, Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents, J Pediatr, 136, 727 Kemmer, 2001, High prevalence of NASH among Mexican American females with tipe II diabetes mellitus, Gastroenterology, 120, A117, 10.1016/S0016-5085(01)80576-X Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466 Caldwell, 2002, Is NASH underdiagnosed among African-Americans?, Am J Gastroenterol, 97, 1496, 10.1111/j.1572-0241.2002.05795.x Lee, 1997, Familial risk ratios for extreme obesity: implications for mapping human obesity genes, Int J Obes Relat Metab Disord, 21, 935, 10.1038/sj.ijo.0800498 Trevisan, 1998, The epidemiology of diabetes mellitus, Nephrol Dial Transplant, 13, 2, 10.1093/ndt/13.suppl_8.2 Struben, 2000, Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds, Am J Med, 108, 9, 10.1016/S0002-9343(99)00315-0 Willner, 2001, Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency and severity of disease, Am J Gastroenterol, 96, 2957, 10.1111/j.1572-0241.2001.04667.x Bataller, 2003, Los polimorfismos genéticos y las enfermedades del hígado, Gastroenterol Hepatol, 26, 307, 10.1157/13046595 Ratziu, 2000, Liver fibrosis in overweight patients, Gastroenterology, 118, 1117, 10.1016/S0016-5085(00)70364-7 Moreno Sánchez, 1991, Esteatohepatitis no alcohólica. Evolución clínica e histological a medio plazo de diez pacientes, Med Clin (Barc), 96, 733 Harrison, 2003, The natural history of non-alcoholic fatty liver disease: a clinical histopathologic study, Am J Gastroenterol, 98, 2042, 10.1111/j.1572-0241.2003.07659.x Fassio, 2004, Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies, Hepatology, 40, 820 Hui, 2005, Histological progression of non-alcoholic fatty liver disease in Chinese patients, Aliment Pharmacol Ther, 21, 407, 10.1111/j.1365-2036.2005.02334.x Nagore, 1988, The pathology of diabetic hepatitis, J Pathol, 156, 155, 10.1002/path.1711560210 Evans, 2002, Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?, J Clin Pathol, 55, 689, 10.1136/jcp.55.9.689 Dam-Larsen, 2004, Long term prognosis of fatty liver: risk of chronic liver disease and death, Gut, 53, 750, 10.1136/gut.2003.019984 Contos, 2001, Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis, Liver Transp, 7, 363, 10.1053/jlts.2001.23011 Andersen, 1991, Hepatic effects of dietary weight loss in morbidly obese subjects, J Hepatol, 12, 224, 10.1016/0168-8278(91)90942-5 Drenick, 1970, Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small bowel bypass, N Engl J Med, 282, 829, 10.1056/NEJM197004092821502 Luyckx, 1998, Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty, Int J Obes Relat Metab Disord, 22, 222, 10.1038/sj.ijo.0800571 Ghany, 2003, Progression of fibrosis in chronic hepatitis C, Gastroenterology, 124, 97, 10.1053/gast.2003.50018 Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168 Shimada, 2002, Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis, J Hepatol, 37, 154, 10.1016/S0168-8278(02)00099-5 Ong, 2002, Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?, Gastroeneterology, 123, 375, 10.1053/gast.2002.34453 Zen, 2001, Hepatocellular carcinoma arising in non-alcoholic steatohepatitis, Pathol Int, 51, 127, 10.1046/j.1440-1827.2001.01174.x Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States, Hepatology, 36, 1349, 10.1053/jhep.2002.36939 Regimbeau, 2004, Obesity and diabetes as a risk factor for hepatocellular carcinoma, Liver Transp, 10, 69, 10.1002/lt.20033 Ratziu, 2002, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, Hepatology, 35, 1485, 10.1053/jhep.2002.33324 Hui, 2003, Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C, Hepatology, 38, 420, 10.1053/jhep.2003.50320 El-Serag, 2004, Hepatocellular carcinoma: recent trends in the United States, Gastroenterology, 127, 27, 10.1053/j.gastro.2004.09.013 McCullough, 2003, Natural history of nonalcoholic steatohepatitis, 219 Sorrentino, 2004, Silent non-alcoholic fatty liver disease - a clinical-histological study, J Hepatol, 41, 751, 10.1016/j.jhep.2004.07.010 Angulo, 2004, Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease, J Hepatol, 41, 943, 10.1016/j.jhep.2004.08.020 Younossi, 2004, Nonalcoholic fatty liver disease in patients with type 2 diabetes, Clin Gastroenterol Hepatol, 2, 262, 10.1016/S1542-3565(04)00014-X Nanji, 1986, Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients, Enzyme, 36, 266, 10.1159/000469304 Fargion, 2001, Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis, Am J Gastroenterol, 96, 2448, 10.1111/j.1572-0241.2001.04052.x Valenti, 2003, Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis, Dig Liver Dis, 35, 172, 10.1016/S1590-8658(03)00025-2 Bugianesi, 2004, Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver, Hepatology, 39, 179, 10.1002/hep.20023 George, 1998, Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis, Gastroenterology, 114, 311, 10.1016/S0016-5085(98)70482-2 Younossi, 1999, Hepatic iron and nonalcoholic fatty liver disease, Hepatology, 30, 847, 10.1002/hep.510300407 Bonkovsky, 1999, Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in nonalcoholic steatohepatitis, J Hepatol, 31, 421, 10.1016/S0168-8278(99)80032-4 Pagano, 2002, Nonalcoholic steatohepatitis, insulin resistence, and metabolic syndrome. Further evidence for an etiologic association, Hepatology, 35, 367, 10.1053/jhep.2002.30690 Pérez-Aguilar, 2004, Estudio de pacientes remitidos por elevación de la ferritina y/o saturación de la transferrina: importancia del hígado graso no alcohólico, Gastroenterol Hepatol, 27, 508, 10.1016/S0210-5705(03)70517-2 Mendler, 1999, Insulin resistance-associated hepatic iron overload, Gastroenterology, 117, 1155, 10.1016/S0016-5085(99)70401-4 Chitturi, 2003, Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis, Curr Gastroenterol Rep, 5, 18, 10.1007/s11894-003-0005-y Solís Herruzo, 2004, Hierro, virus C y esteatosis hepática, Rev Esp Enferm Dig, 96, 809, 10.4321/S1130-01082004000100001 Laine, 2004, Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption, Hepatology, 39, 1639, 10.1002/hep.20219 Rosenberg, 2004, Serum markers detect the presence of liver fibrosis: a cohort study, Gastroenterology, 127, 1704, 10.1053/j.gastro.2004.08.052 Klain, 1989, Liver histology abnormalities in the morbidly obese, Hepatology, 10, 873, 10.1002/hep.1840100521 Hilden, 1973, Fatty liver persisting for up to 33 years, Acta Med Scand, 194, 485, 10.1111/j.0954-6820.1973.tb19478.x Adler, 1979, Fatty liver hepatitis and cirrhosis in obese patients, Am J Med, 67, 811, 10.1016/0002-9343(79)90740-X Gines, 1987, Compensated cirrhosis: natural history and prognostic factors, Hepatology, 7, 122, 10.1002/hep.1840070124 Sasaki, 1989, Mortality and causes of death in type 2 diabetic patients: a long-term followup study in Osaka District, Japan, Diabetes Res Clin Prac, 7, 33, 10.1016/0168-8227(89)90042-9